These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8121079

  • 1. Intracerebroventricular treatment with vasopressin V1-receptor antagonist inhibits centrally-mediated pressor response to clonidine in conscious rats.
    Nakamura S, Kawasaki H, Takasaki K.
    Jpn J Pharmacol; 1993 Dec; 63(4):447-53. PubMed ID: 8121079
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
    Solomon RE, Brody MJ, Gebhart GF.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):27-38. PubMed ID: 2571720
    [Abstract] [Full Text] [Related]

  • 5. Central alpha 2-adrenoceptor-mediated pressor response to clonidine in conscious, spontaneously hypertensive rats.
    Kawasaki H, Nakamura S, Takasaki K.
    Jpn J Pharmacol; 1992 Jul; 59(3):321-31. PubMed ID: 1331587
    [Abstract] [Full Text] [Related]

  • 6. Furosemide inhibits the centrally-mediated pressor response to clonidine in conscious, normotensive rats.
    Kawasaki H, Nakamura S, Takasaki K.
    Br J Pharmacol; 1991 Nov; 104(3):629-32. PubMed ID: 1797326
    [Abstract] [Full Text] [Related]

  • 7. Age-related decrease in centrally-mediated pressor response to clonidine in conscious rats.
    Kawasaki H, Araki H, Futagami K, Gomita Y.
    Brain Res; 1998 Jan 26; 782(1-2):333-6. PubMed ID: 9519283
    [Abstract] [Full Text] [Related]

  • 8. Central alpha-2 adrenoceptor-mediated hypertensive response to clonidine in conscious, normotensive rats.
    Kawasaki H, Takasaki K.
    J Pharmacol Exp Ther; 1986 Mar 26; 236(3):810-8. PubMed ID: 3005557
    [Abstract] [Full Text] [Related]

  • 9. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.
    Maione S, Vitagliano S, Berrino L, Lampa E, Rossi F.
    Neuropharmacology; 1992 Apr 26; 31(4):403-7. PubMed ID: 1355901
    [Abstract] [Full Text] [Related]

  • 10. Evidence for central alpha 2-adrenoceptor-mediated hypertension in freely moving, normotensive rats.
    Kawasaki H, Takasaki K.
    Arch Int Pharmacodyn Ther; 1987 Oct 26; 289(2):217-33. PubMed ID: 2892472
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin inhibits the centrally mediated hypertensive response to clonidine in freely moving rats.
    Kawasaki H, Nakamura S, Takasaki K.
    Neurosci Lett; 1991 Feb 25; 123(2):232-5. PubMed ID: 1674124
    [Abstract] [Full Text] [Related]

  • 12. Interaction of opioids and vasopressin in central action of angiotensin II in conscious rabbits.
    Fukuhara M, Matsumura K, Abe I, Fujishima M.
    Hypertens Res; 1998 Jun 25; 21(2):89-95. PubMed ID: 9661804
    [Abstract] [Full Text] [Related]

  • 13. Pressor and bradycardic effects of centrally administered relaxin in conscious rats.
    Yang RH, Bunting S, Wyss JM, Berecek KH, Zhang L, Jin H.
    Am J Hypertens; 1995 Apr 25; 8(4 Pt 1):375-81. PubMed ID: 7619350
    [Abstract] [Full Text] [Related]

  • 14. Effects of natriuretic peptides on the centrally mediated pressor response to clonidine in freely moving rats.
    Nakamura S, Kawasaki H, Takasaki K.
    Jpn J Pharmacol; 1991 Nov 25; 57(3):443-6. PubMed ID: 1839909
    [Abstract] [Full Text] [Related]

  • 15. Tachycardic and hypertensive effects of centrally administered clonidine in conscious rats.
    Imai Y, Nolan PL, Johnston CI.
    Clin Exp Hypertens A; 1986 Nov 25; 8(2):239-58. PubMed ID: 3720002
    [Abstract] [Full Text] [Related]

  • 16. Central and systemic effects of a vasopressin V1 antagonist on MAP recovery after haemorrhage in rats.
    Johnson JV, Bennett GW, Hatton R.
    J Cardiovasc Pharmacol; 1988 Oct 25; 12(4):405-12. PubMed ID: 2465440
    [Abstract] [Full Text] [Related]

  • 17. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G, De Wied D.
    Brain Res; 1997 Jun 06; 759(1):18-23. PubMed ID: 9219858
    [Abstract] [Full Text] [Related]

  • 18. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms.
    Dedeoğlu A, Fisher LA.
    J Pharmacol Exp Ther; 1991 Dec 06; 259(3):1027-34. PubMed ID: 1762059
    [Abstract] [Full Text] [Related]

  • 19. Choline administration reverses hypotension in spinal cord transected rats: the involvement of vasopressin.
    Savci V, Ulus IH.
    Neurochem Res; 1998 May 06; 23(5):733-41. PubMed ID: 9566613
    [Abstract] [Full Text] [Related]

  • 20. Central cardiovascular effects of AVP and AVP analogs with V1, V2 and 'V3' agonistic or antagonistic properties in conscious dog.
    Noszczyk B, Lon S, Szczepańska-Sadowska E.
    Brain Res; 1993 Apr 30; 610(1):115-26. PubMed ID: 8518919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.